BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  BMS Preps Lupus Treatment to Become Third Approval in Space

  Bristol Myers Squibb (BMS) has announced late-breaking data showing deucravacitinib significant efficacy at the primary endpoint for the treatment of systemic lupus erythematosus (SLE).

  June 1, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Sanofi, Sobi and Midatech Gain FDA’s Vote of Confidence in Hemophilia, Cancer

  The FDA has issued special designations that could improve the lives of millions with recurrent glioblastoma or hemophilia diagnoses.

  June 1, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano M.S.
• 

  Novel Herpesvirus Research, Vaccines Breaking Ground

  There are more than 100 known herpesviruses, eight of which infect only humans. Here’s a look at recent stories and research on herpesviruses.

  June 1, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Transcranial Pulse Stimulation for Alzheimer’s: Legitimate Treatment or Pseudoscience?

  A largely untested and unproven treatment for Alzheimer’s disease, called transcranial pulse stimulation (TPS), is becoming popular around the world, although experts are skeptical.

  June 1, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Genetown

  MassBio Report Highlights Hiring Struggles in the Life Sciences Industry

  In a recent Massachusetts Biotechnology Council survey, 94.2% of respondents reported having difficulty hiring experienced workers.

  June 1, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Career Advice

  Logistical skills: The Panacea The Pharma Sector Needs

  With a swirl of rumors around the changes in ownership in the pharma industry, this invariably triggers reviews of business strategies. Because of this, wider skillsets from related sectors are needed.

  June 1, 2022

   · 

  4 min read

   · 

  Leigh Anderson
• 

  Business

  Passage Bio CEO Bruce Goldsmith Abruptly Steps Down

  Although Bruce Goldsmith will no longer serve on the executive team, he will remain with Passage Bio for a short period as a strategic advisor to the interim CEO.

  June 1, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Report Predicts AbbVie Could Become Top-Selling Pharma Company by 2028

  The report suggests that AbbVie’s sales will be approximately $65.7 billion within the next six years, with Roche right behind at $65 billion.

  June 1, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Biopharma Companies Team Up to Fight Diabetes, Alzheimer’s and Cancer

  Several new biotech and biopharma companies are sharing their strengths to develop new treatments for high-need diseases diabetes, Alzheimer’s and cancer.

  June 1, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Business

  Gene-Editing the Microbiome: The Limitless Possibilities

  Eligo Bioscience has thought of a way to solve the dysbiosis between our bodies and our microbiomes – gene editing. BioSpace spoke with Eligo Co-founder and CEOXavier Duportet, Ph.D.

  June 1, 2022

   · 

  5 min read

   · 

  Hayley Shasteen